Cosmos Health Inc. Cash Flow Conversion Efficiency
Cosmos Health Inc. cash flow conversion efficiency. Based on the latest financial reports, Cosmos Health Inc. (COSM) has a cash flow conversion efficiency ratio of -0.249x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.60 Million) by net assets ($18.42 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Cosmos Health Inc. (2010–2025)
Cash flow conversion efficiency of Cosmos Health Inc. from 2010 to 2025. This chart illustrates how Cosmos Health Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View Cosmos Health Inc. stock price for real-time trading data and today's change.
Cosmos Health Inc. Cash Flow Conversion Ratio Explained
Cosmos Health Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Cosmos Health Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cosmos Health Inc. ranked by their cash flow conversion efficiency. Also see Cosmos Health Inc. (COSM) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beeio Honey Ltd
TA:WTS
|
-0.332x |
|
Dong Won Fish
KO:030720
|
0.073x |
|
Builders Capital Mortgage Corp
V:BCF
|
N/A |
|
Adler Group SA
F:ADJ
|
-0.053x |
|
Podium Minerals Ltd
AU:POD
|
-0.035x |
|
BIORETEC OY
F:0TN
|
N/A |
|
Enry S Island Spa Sb
VI:EIOS
|
N/A |
|
SeaTwirl AB
ST:STW
|
-0.076x |
Annual Cash Flow Conversion Efficiency for Cosmos Health Inc. (2010–2025)
The table below shows the annual cash flow conversion efficiency of Cosmos Health Inc. from 2010 to 2025. Review free cash flow generation of Cosmos Health Inc. to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $18.42 Million | $-8.45 Million | -0.458x | -45.76% |
| 2024-12-31 | $24.53 Million | $-7.72 Million | -0.315x | +27.49% |
| 2023-12-31 | $36.04 Million | $-15.64 Million | -0.434x | -15.69% |
| 2022-12-31 | $39.66 Million | $-14.87 Million | -0.375x | +76.86% |
| 2021-12-31 | $4.38 Million | $-7.10 Million | -1.621x | -158.63% |
| 2020-12-31 | $-4.16 Million | $-11.50 Million | 2.764x | +272.92% |
| 2019-12-31 | $-6.46 Million | $-4.79 Million | 0.741x | +58.10% |
| 2018-12-31 | $-3.32 Million | $-1.56 Million | 0.469x | -83.80% |
| 2017-12-31 | $-3.03 Million | $-8.76 Million | 2.893x | +138.52% |
| 2016-12-31 | $-1.75 Million | $-2.13 Million | 1.213x | +204.48% |
| 2015-12-31 | $-1.25 Million | $-497.09K | 0.398x | -66.58% |
| 2014-12-31 | $5.47 Million | $6.53 Million | 1.192x | +107.70% |
| 2013-12-31 | $-53.68K | $831.40K | -15.487x | -67992.51% |
| 2012-12-31 | $-1.36K | $31.00 | -0.023x | -100.12% |
| 2011-12-31 | $-4.76K | $-87.29K | 18.330x | +360.38% |
| 2010-12-31 | $-17.48K | $-69.60K | 3.982x | -- |
About Cosmos Health Inc.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It als… Read more